CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 49 filers reported holding CYTEIR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,985,184 | +9.2% | 2,459,572 | 0.0% | 15.71% | +44.0% |
| Q2 2023 | $6,394,887 | +42.9% | 2,459,572 | 0.0% | 10.91% | +22.1% |
| Q1 2023 | $4,476,421 | +10.3% | 2,459,572 | 0.0% | 8.93% | +34.8% |
| Q4 2022 | $4,058,294 | -14.4% | 2,459,572 | -0.4% | 6.63% | -10.3% |
| Q3 2022 | $4,742,000 | -35.9% | 2,469,572 | -0.2% | 7.38% | -27.5% |
| Q2 2022 | $7,399,000 | -20.7% | 2,474,572 | 0.0% | 10.18% | +43.4% |
| Q1 2022 | $9,329,000 | -66.8% | 2,474,572 | 0.0% | 7.10% | -44.0% |
| Q4 2021 | $28,136,000 | – | 2,474,572 | – | 12.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,459,572 | $4,058,294 | 6.63% |
| Novo Holdings A/S | 3,940,413 | $6,501,681 | 0.41% |
| Newtyn Management, LLC | 1,020,000 | $1,683,000 | 0.35% |
| Avidity Partners Management LP | 1,795,800 | $2,963,070 | 0.06% |
| CAAS CAPITAL MANAGEMENT LP | 459,779 | $758,636 | 0.05% |
| Baker Brothers Advisors | 2,492,118 | $4,111,995 | 0.02% |
| RBF Capital, LLC | 151,282 | $250,000 | 0.02% |
| Cannell Capital | 19,684 | $32,479 | 0.01% |
| Evercore Wealth Management, LLC | 146,676 | $242,015 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 119,584 | $197,314 | 0.01% |